高价位也是从低价位上来的，所以低价位有一定投机性。高价位是已经被证明了的，要上还需要更有力的推力，不容易的。各有利弊。

所有跟帖： 

• 特别是生药。JAZZ，ALNY，ISIS，，，这些股在1~2B大部介入是最好时机，JMO -buydip?- ♀ (0 bytes) () 04/15/2015 postreply 17:02:41

• 谁是下一个JAZZ, ALNY? -valuetest- ♂ (10 bytes) () 04/15/2015 postreply 17:15:37

• ACAD. I could be wrong though. -buydip?- ♀ (0 bytes) () 04/15/2015 postreply 17:21:14

• 先谢了. 可能还有这些： -valuetest- ♂ (82 bytes) () 04/15/2015 postreply 17:31:29

• 再提一个，NLNK -buydip?- ♀ (0 bytes) () 04/15/2015 postreply 17:30:33

• XON -三丝- ♂ (0 bytes) () 04/15/2015 postreply 20:45:54

• 考察中， -牛经沧海- ♂ (0 bytes) () 04/16/2015 postreply 03:32:08

• 高价位的抓住好时机也能翻好几倍，例如1998-2000年的msft/csco/dell,最近几年的aapl -valuetest- ♂ (20 bytes) () 04/15/2015 postreply 17:09:15

• ALL IS ABOUT VALUATION, AAPL IS NOT EXPENSIVE NOW. -buydip?- ♀ (0 bytes) () 04/15/2015 postreply 17:11:34

• 同意， valuation 其实相当matter -valuetest- ♂ (10 bytes) () 04/15/2015 postreply 17:16:56